Journalist Joan Lunden Discusses Her Breast Cancer Diagnosis and Treatment


Roy Firestone interviews longtime journalist, author and television host Joan Lunden on her recent breast cancer diagnosis and treatment.

Roy Firestone interviews longtime journalist, author and television host Joan Lunden on her recent breast cancer diagnosis and treatment.

Lunden announced her diagnosis of breast cancer in June and has been public about her cancer experience. She tells Firestone that she has been overwhelmed with people's support since sharing her journey. "The fact that these people take the time every day to just write a little message or pray for you, stay strong, or share their tips or advice. It has been a very big part of my healing and just keeping me strong," she says.

Lunden recounts how the cancer was first identified—not during a routine mammogram, but by ultrasound. Lunden shares a conversation she had in a past interview with the well-known breast cancer surgeon, Susan M. Love, on dense breast tissue and the need for additional screening for certain women who have dense breasts. For the past few years, Lunden said, she has been getting both screening procedures because past mammograms showed the journalist had dense breast tissue.

"To me, one of my great passions is to make women more aware of their bodies, their breasts and the fact that they need to know whether or not they have dense breast tissue," she says.

Lunden also shares how she made the decision to get a second opinion, results of her genetic testing, and how she made her final treatment choice.

"We decided to go with this latest regimen, which seemed to us to be the one that would maybe give me my best chances for success and my best chances to not have a reccurrence of the disease."

Making the final decision was tough, she said, especially with different recommendations from two world renowned medical professionals, but she ultimately went with a newer treatment regimen. In addition to the newer regimen, she also discussed with her doctor about having surgery after chemotherapy. She has since completed both chemotherapy and surgery, and has begun radiation treatments.

CURE magazine will feature Lunden's story in the February 2015 issue. You can subscribe to CURE for free at

Related Videos
Image of Kristen Dahlgren at Extraordinary Healer.
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Related Content